The Clorox Company

NYSE:CLX

Household & Personal Products

Consumer Defensive
$108.39 -2.60%

-$2.54 today

Market cap
$13.13B
Beta
0.55
P/E (TTM)
15.2
EPS (TTM)
$6.23
Dividend yield
5.22%
52W Low $84.70High $132.03

Volume 2.16M

Average 2.84M

CLX Net Income

Bottom-line profit, the starting point for calculating cash from operations.

The Clorox CompanyNYSE: CLX

Net Income · Q1 FY2027 · quarter ended Sep 2026

Net income growth accelerates

Q1 FY2027 net income of $170M rose 107.3% year over year, ahead of the -14.2% change in trailing-twelve-month net income. Sequentially, it fell 2.9% from the prior quarter. Over 3 fiscal years it compounded at +55.1% a year.

Context

  • Net income amounted to 8.9% of revenue in FY2026, down 2.7 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 12 analysts of $701.22M (+16.7%) for the fiscal year ending Jun 2027, a step up from the -27.1% reported in FY2026.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$170M-2.9% QoQ
Last fiscal yearJun 2026
$601M-27.1% YoY
LTMSep 2026
$689M-14.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.3%-23.5%-130.8 pp
1 year-27.1%+16.7%+43.7 pp
3-year CAGR+55.1%+10.8%-44.4 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2026
601M USD
Year-over-year change
-27.1%
4-year CAGR
+6.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How CLX compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -14.2% is the 6th highest of 10, against a peer median of -4.4%.
  • Net income amounts to 9.6% of revenue for CLX, versus a peer median of 10.1%.
CLX Competitors
Net Income for CLX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PGThe Procter & Gamble CompanyLTM Sep 2026$16.12B USD-4.4%+3.1%18.3%
ULUnilever PLCFY2025€9.47B EUR+64.9%+7.4%18.7%
CLColgate-Palmolive CompanyLTM Sep 2026$2.14B USD-29.6%+2.7%10.1%
KMBKimberly-Clark CorporationLTM Jun 2026$1.99B USD-19.5%+1.5%12.0%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$774.8M USD-1.0%+21.2%12.4%
KVUEKenvue Inc.LTM Sep 2026$760M USD-47.0%-11.0%4.9%
CLXThe Clorox CompanyLTM Sep 2026$689M USD-14.2%+55.1%9.6%
REYNReynolds Consumer Products Inc.LTM Jun 2026$344M USD+10.3%+5.3%9.1%
SPBSpectrum Brands Holdings, Inc.LTM Jun 2026$136.7M USD+128.6%—4.8%
EPCEdgewell Personal Care CompanyLTM Mar 2026$41.3M USD-148.8%-36.6%2.0%
HELEHelen of Troy LimitedLTM Dec 2025$0 USD———
Peer median (excluding CLX) —-4.4%+2.9%10.1%

Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Net Income471M161M292M824M601M
Depreciation & Amortization224M236M235M219M247M
Deferred Income Tax5M(149M)(100M)(18M)81M
Stock-Based Compensation52M73M74M81M48M
Change in Working Capital(99M)354M(241M)(211M)118M
Accounts Receivables(84M)(13M)(34M)(145M)151M
Inventory(18M)58M55M63M(71M)
Accounts Payables(47M)157M(140M)(124M)38M
Other Working Capital50M152M(122M)(5M)0
Other Non-Cash Items133M483M435M86M(483M)
Operating Cash Flow786M1.16B695M981M612M
Capital Expenditures(251M)(228M)(212M)(220M)(207M)
Acquisitions (Net)0017M128M(2.1B)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities22M5M20M(2M)10M
Investing Cash Flow(229M)(223M)(175M)(94M)(2.3B)
Debt Repayment(83M)(188M)(45M)02.57B
Common Stock Issued5M33M1M26M(23M)
Common Stock Repurchased(25M)00(332M)(256M)
Dividends Paid(571M)(583M)(595M)(602M)(602M)
Other Financing Activities(15M)(15M)(16M)(16M)(16M)
Financing Cash Flow(689M)(753M)(655M)(924M)1.67B
Effect of Forex Changes(6M)2M(26M)2M(2M)
Net Change in Cash(138M)184M(161M)(35M)(23M)
Free Cash Flow535M930M483M761M405M

The Clorox Company

NYSE:CLX

Intrinsic Alpha fair value

Locked

Current Price

$108.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.